Compositions and methods to treat acute myelogenous leukemia

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 35/02 (2006.01)

Patent

CA 2758548

Compositions and methods for treating or preventing a hematologic malignancy, such as AML, using an anti-alpha4 antibody in combination with chemotherapy agents in a therapeutically effective amount The method includes administering to the patient a therapeutically effective amount of a composition containing an antagonist of an interaction between an integnn with an alpha4 subunit (VLA-4) and a ligand for this integnn (VCAM-1)

L'invention porte sur des compositions et sur des procédés pour le traitement ou la prévention d'une malignité hématologique, telle qu'un AML, à l'aide d'un anticorps anti-alpha4 en combinaison avec des agents de chimiothérapie dans une quantité thérapeutiquement efficace. Le procédé comprend l'administration au patient d'une quantité thérapeutiquement efficace d'une composition contenant un antagoniste d'une interaction entre une intégrine avec une sous-unité alpha4 (VLA-4) et un ligand pour cette intégrine (VCAM-1).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods to treat acute myelogenous leukemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods to treat acute myelogenous leukemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods to treat acute myelogenous leukemia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1782534

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.